Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR)

2020, Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1204, 10.1016/S0140-6736(20)30925-9 Chung, 2014, International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma, Eur Respir J, 43, 343, 10.1183/09031936.00202013 Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2022. Available at: https://ginasthma.org/gina-reports/. Accessed September 6, 2023. Chastek, 2016, Economic burden of illness among patients with severe asthma in a managed care setting, J Manag Care Spec Pharm, 22, 848 Price, 2014, Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey, NPJ Prim Care Respir Med, 24, 14009, 10.1038/npjpcrm.2014.9 Gerhardsson de Verdier, 2017, Seasonal and geographic variations in the incidence of asthma exacerbations in the United States, J Asthma, 54, 818, 10.1080/02770903.2016.1277538 DuBuske, 2018, Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab, Allergy Asthma Proc, 39, 345, 10.2500/aap.2018.39.4162 Staton, 2017, Seasonal variability of severe asthma exacerbations and clinical benefit from lebrikizumab, J Allergy Clin Immunol, 139, 10.1016/j.jaci.2017.01.028 Szefler, 2019, Seasonal variation in asthma exacerbations in the AUSTRI and VESTRI studies, ERJ Open Res, 5, 00153, 10.1183/23120541.00153-2018 Corren, 2021, Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma: a post hoc analysis of the PATHWAY phase 2b study, J Asthma Allergy, 14, 1, 10.2147/JAA.S286036 Gauvreau, 2015, Allergen-induced airway responses, Eur Respir J, 46, 819, 10.1183/13993003.00536-2015 Adeli, 2019, Asthma exacerbation related to viral infections: an up to date summary, J Fam Med Prim Care, 8, 2753, 10.4103/jfmpc.jfmpc_86_19 Kloepfer, 2010, Virus/allergen interactions and exacerbations of asthma, Immunol Allergy Clin North Am, 30, 553, 10.1016/j.iac.2010.08.002 Larsen, 2016, The annual September peak in asthma exacerbation rates, Ann Am Thorac Soc, 13, 231, 10.1513/AnnalsATS.201508-545OC Satia, 2020, Emergency department visits and hospitalisations for asthma, COPD and respiratory tract infections: what is the role of respiratory viruses, and return to school in September, January and March?, ERJ Open Res, 6, 00593, 10.1183/23120541.00593-2020 Julious, 2011, Seasonality of medical contacts in school-aged children with asthma: association with school holidays, Public Health, 125, 769, 10.1016/j.puhe.2011.08.005 Gauvreau, 2014, Effects of an anti-TSLP antibody on allergen-induced asthmatic responses, N Engl J Med, 370, 2102, 10.1056/NEJMoa1402895 Gauvreau, 2020, Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma, Expert Opin Ther Targets, 24, 777, 10.1080/14728222.2020.1783242 Hammond, 2015, Rhinovirus and asthma: a storied history of incompatibility, Curr Allergy Asthma Rep, 15, 502, 10.1007/s11882-014-0502-0 Lee, 2012, Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection, J Allergy Clin Immunol, 130, 10.1016/j.jaci.2012.07.031 Nino, 2014, Directional secretory response of double stranded RNA-induced thymic stromal lymphopoetin (TSLP) and CCL11/eotaxin-1 in human asthmatic airways, PLoS One, 9, 10.1371/journal.pone.0115398 Lay, 2015, Human metapneumovirus infection activates the TSLP pathway that drives excessive pulmonary inflammation and viral replication in mice, Eur J Immunol, 45, 1680, 10.1002/eji.201445021 Li, 2011, Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways, J Allergy Clin Immunol, 128, 10.1016/j.jaci.2011.06.041 Zheng, 2010, TSLP and downstream molecules in experimental mouse allergic conjunctivitis, Invest Ophthalmol Vis Sci, 51, 3076, 10.1167/iovs.09-4122 Lv, 2018, Airway epithelial TSLP production of TLR2 drives type 2 immunity in allergic airway inflammation, Eur J Immunol, 48, 1838, 10.1002/eji.201847663 Ortega, 2014, The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia, Eur Respir J, 44, 239, 10.1183/09031936.00220413 Corren, 2020, Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma, J Allergy Clin Immunol Pract, 8, 516, 10.1016/j.jaip.2019.08.050 Sverrild A, Cerps S, Nieto-Fontarigo J, Ramu S, Hvidtfeldt M, Menzel M, et al. Effects of tezepelumab on bronchial epithelial resistance and tolerance to viral stimulation in patients with uncontrolled asthma. Eur Respir J, in press. Corren, 2023, Efficacy of tezepelumab in patients with evidence of severe allergic asthma: results from the phase 3 NAVIGATOR study, Clin Exp Allergy, 53, 417, 10.1111/cea.14256 Menzies-Gow, 2020, NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma, Respir Res, 21, 266, 10.1186/s12931-020-01526-6 Menzies-Gow, 2021, Tezepelumab in adults and adolescents with severe, uncontrolled asthma, N Engl J Med, 384, 1800, 10.1056/NEJMoa2034975 Abu Khweek, 2020, Insights into mucosal innate immune responses in house dust mite-mediated allergic asthma, Front Immunol, 11, 10.3389/fimmu.2020.534501 Migueres, 2014, Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease, Clin Transl Allergy, 4, 16, 10.1186/2045-7022-4-16 Popescu, 2014, Molecular biomarkers for grass pollen immunotherapy, World J Methodol, 4, 26, 10.5662/wjm.v4.i1.26 McCarty, 2014, Identifying asthma triggers, Otolaryngol Clin North Am, 47, 109, 10.1016/j.otc.2013.08.012 Olofsson, 2011, PCR for detection of respiratory viruses: seasonal variations of virus infections, Expert Rev Anti-Infect Ther, 9, 615, 10.1586/eri.11.75 Jartti, 2020, Role of viruses in asthma, Semin Immunopathol, 42, 61, 10.1007/s00281-020-00781-5 Pike, 2018, Interventions for autumn exacerbations of asthma in children, Paediatr Respir Rev, 27, 37 Nitschke, 2022, Association between grass, tree and weed pollen and asthma health outcomes in Adelaide, South Australia: a time series regression analysis, BMJ Open, 12, 10.1136/bmjopen-2022-066851 Lintner, 1993, The effects of season, climate, and air-conditioning on the prevalence of Dermatophagoides mite allergens in household dust, J Allergy Clin Immunol, 91, 862, 10.1016/0091-6749(93)90343-E Zhou, 2005, Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice, Nat Immunol, 6, 1047, 10.1038/ni1247 Diver, 2021, Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial, Lancet Respir Med, 9, 1299, 10.1016/S2213-2600(21)00226-5 Busse, 2011, Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children, N Engl J Med, 364, 1005, 10.1056/NEJMoa1009705 Corren, 2021, Efficacy of tezepelumab in patients with severe, uncontrolled asthma and perennial allergy, J Allergy Clin Immunol Pract, 9, 10.1016/j.jaip.2021.07.045